Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, Ohno Y, Eto T, Harada M, Nagafuji K. Kamezaki K, et al. Among authors: aoki k. Bone Marrow Transplant. 2007 May;39(9):523-7. doi: 10.1038/sj.bmt.1705649. Epub 2007 Mar 19. Bone Marrow Transplant. 2007. PMID: 17369863 Clinical Trial.
Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M. Yakushiji K, et al. Among authors: aoki k. Bone Marrow Transplant. 2002 Apr;29(7):599-606. doi: 10.1038/sj.bmt.1703513. Bone Marrow Transplant. 2002. PMID: 11979310
A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.
Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, Henzan H, Himeji D, Koyama T, Miyake K, Inoue Y, Nakashima H, Otsuka T, Tanaka Y, Nagasawa K, Harada M. Tsukamoto H, et al. Among authors: aoki k. Ann Rheum Dis. 2006 Apr;65(4):508-14. doi: 10.1136/ard.2005.037879. Epub 2005 Aug 26. Ann Rheum Dis. 2006. PMID: 16126798 Free PMC article. Clinical Trial.
Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, Henzan H, Kamezaki K, Takenaka K, Miyamoto T, Teshima T, Harada M, Akashi K. Kohno K, et al. Among authors: aoki k. Transpl Infect Dis. 2009 Aug;11(4):318-23. doi: 10.1111/j.1399-3062.2009.00401.x. Epub 2009 May 11. Transpl Infect Dis. 2009. PMID: 19453993 Clinical Trial.
Unrelated cord blood transplantation in CML: Japan Cord Blood Bank Network analysis.
Nagamura-Inoue T, Kai S, Azuma H, Takanashi M, Isoyama K, Kato K, Takahashi S, Taniguchi S, Miyamura K, Aoki K, Hidaka M, Nagamura F, Tojo A, Fang X, Kato S; Japan Cord Blood Bank Network. Nagamura-Inoue T, et al. Among authors: aoki k. Bone Marrow Transplant. 2008 Aug;42(4):241-51. doi: 10.1038/bmt.2008.164. Epub 2008 Jun 23. Bone Marrow Transplant. 2008. PMID: 18574449
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.
Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, Nakayama K. Shimoda K, et al. Among authors: aoki k. Immunity. 2000 Oct;13(4):561-71. doi: 10.1016/s1074-7613(00)00055-8. Immunity. 2000. PMID: 11070174 Free article.
3,417 results